Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
暂无分享，去创建一个
F. Speleman | J. Vandesompele | J. Marine | M. Michaelis | A. De Paepe | J. Cinatl | C. Cuvelier | N. Yigit | A. Rihani | M. Bracke | I. Lambertz | L. Vercruysse | T. Van Maerken | L. Ferdinande | J. Taildeman